NEXT Financial Group, Inc - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 188 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$080.0%0.00%
Q3 2021$08
-70.4%
0.00%
Q2 2021$0
-100.0%
27
-97.2%
0.00%
-100.0%
Q1 2021$25,000
-10.7%
962
+85.4%
0.00%
-33.3%
Q4 2020$28,000
+33.3%
519
+3.8%
0.00%
+50.0%
Q3 2020$21,000
+23.5%
500
+25.0%
0.00%0.0%
Q4 2019$17,000
+466.7%
400
+300.0%
0.00%
Q2 2019$3,000
-98.6%
100
-98.8%
0.00%
-100.0%
Q1 2019$215,000
+37.8%
8,000
-17.0%
0.05%
+68.8%
Q4 2018$156,000
-11.4%
9,637
+13.4%
0.03%
-61.0%
Q3 2018$176,000
+2414.3%
8,500
+4150.0%
0.08%
+4000.0%
Q3 2017$7,000
-99.9%
2000.0%0.00%
+100.0%
Q2 2017$6,000,000
-14.3%
2000.0%0.00%
-50.0%
Q1 2017$7,000,000
+16.7%
2000.0%0.00%
+100.0%
Q4 2016$6,000,000
+99900.0%
2000.0%0.00%0.0%
Q3 2016$6,0000.0%2000.0%0.00%
-50.0%
Q2 2016$6,000
-53.8%
200
-60.0%
0.00%
-60.0%
Q1 2016$13,000
-75.5%
500
-66.7%
0.01%
-75.0%
Q4 2015$53,000
+15.2%
1,500
+7.1%
0.02%
+25.0%
Q3 2015$46,000
-54.0%
1,400
-41.7%
0.02%
-52.9%
Q2 2015$100,000
+23.5%
2,400
-4.0%
0.03%
+30.8%
Q1 2015$81,000
+2.5%
2,5000.0%0.03%0.0%
Q4 2014$79,000
+27.4%
2,5000.0%0.03%
+116.7%
Q3 2014$62,000
+17.0%
2,5000.0%0.01%
-57.1%
Q2 2014$53,0002,5000.03%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders